Chagas disease: changes in knowledge and management
Authors:
- François-Xavier LescureFLFrançois-Xavier Lescure
- Guillaume Le LoupGLGuillaume Le Loup
- Hector FreilijHFHector Freilij
- Michel DevelouxMDMichel Develoux
- Luc ParisLPLuc Paris
- Laurent BrutusLBLaurent Brutus
- Gilles PialouxGPGilles Pialoux
- 1 August 2010
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 10 (8) , 556-570
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment EfficacyClinical Infectious Diseases, 2009
- Field Evaluation of a Rapid Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of Whole BloodJournal of Clinical Microbiology, 2008
- Current concepts in immunoregulation and pathology of human Chagas diseaseCurrent Opinion in Infectious Diseases, 2008
- Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas diseaseNature Medicine, 2008
- Transmission of Tropical and Geographically Restricted Infections during Solid-Organ TransplantationClinical Microbiology Reviews, 2008
- Sustainable vector control and management of Chagas disease in the Gran Chaco, ArgentinaProceedings of the National Academy of Sciences, 2007
- The Anti-Trypanosoma cruziActivity of Posaconazole in a Murine Model of Acute Chagas' Disease Is Less Dependent on Gamma Interferon than That of BenznidazoleAntimicrobial Agents and Chemotherapy, 2007
- The Genome Sequence of Trypanosoma cruzi , Etiologic Agent of Chagas DiseaseScience, 2005
- Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruziParasitology Research, 2002
- Left ventricular cineangiography in Chagas' disease: Detection of early myocardial damageAmerican Heart Journal, 1982